KPWS
UTHR icon

Kestra Private Wealth Services’s United Therapeutics UTHR Stock Holding History

Kestra Private Wealth Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Sell
2,059
-197
-9% -$111K 0.01% 843
2026
Q1 		$1.34M Sell
2,256
-99
-4% -$49.3K 0.02% 700
2025
Q4 		$1.15M Buy
2,355
+1,347
+134% +$627K 0.01% 745
2025
Q3 		$423K Sell
1,008
-12
-1% -$4.04K 0.01% 1183
2025
Q2 		$293K Buy
+1,020
New +$305K ﹤0.01% 1294

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Kestra Private Wealth Services's UTHR Position: Q2 2026 in Review

Kestra Private Wealth Services reduced its United Therapeutics (UTHR) stake by 8.7% in Q2 2026, selling an estimated $111K and leaving 2,059 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #843.

Kestra Private Wealth Services first reported a position in UTHR in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.34M in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Kestra Private Wealth Services held 2,059 shares of United Therapeutics worth $1.12M as of Q2 2026.
  • Kestra Private Wealth Services sold 197 United Therapeutics shares in Q2 2026, an estimated $111K.
  • United Therapeutics made up 0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #843 holding.
  • Kestra Private Wealth Services first reported a position in United Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Kestra Private Wealth Services's United Therapeutics position peaked at $1.34M in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.